Skip to content

Kinetix Health Group

The Deal

Bought By
John Ribble
Year
Not published by any primary source
The backer's card prints an Acquired 2025 label; the company's own August 2026 release signs him chief executive officer, dates the combination of its two predecessors to July 2025 and names no buyer, so nothing on it dates the purchase.
Vehicle
A CEO-in-Residence purchase at Brydon Group, which funded it
Kind
Services

A provider of medical communications and commercialization services for biopharma companies specializing in rare disease, in the backer's words.

What Happened Next

Still held: the backer's portfolio card pairs him with the company under an Acquired 2025 label, and the company's own August 2026 release names him chief executive officer of the group.

The exit ends of journeys like this one, where the buyer has announced the purchase itself, are on Buyers.

Backed by the Same Firms

Brydon Group

Method & Source

This record is double-sourced: it joined when the purchase and, where the company has traded on, the exit could both be read in primary accounts rather than inferred.